Open Public Hearing

1
Open Public Hearing

• 1. Kenneth Duckworth
• National Alliance for
• the Mentally Ill

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
2
Open Public Hearing

• 2. Julie Totten
• Families for Depression Awareness

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
3
Open Public Hearing

• 3. Ronnie Wilkins
• American College of Neuropsychopharmacology

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
4
Open Public Hearing

• 4. Ann Blake Tracy
• Marion Goff
• International Coalition for Drug Awareness

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
5
Open Public Hearing

• 5. Andrew Chmilewsky

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
6
Open Public Hearing

• 6. Susan Furlough

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
7
Open Public Hearing

• 7. Lisa van Syckel

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
8
Open Public Hearing

• 8. Raul Lagurre

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
9
Open Public Hearing

• 9. Gloria Pope
• Depression and Bipolar Support Alliance

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
10
Open Public Hearing

• 10. Andy Vickery

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
11
Open Public Hearing

• 12. Vera Sharav
• Alliance for Human Research Protection

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
12
Open Public Hearing

• 14. Jennifer Tierney

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
13
Open Public Hearing

• 15. Alen Salerian

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
14
Open Public Hearing

• 16. Sara Bostock

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
15
Open Public Hearing

• 17. David Fassler
• American Psychiatric Association

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
16
Open Public Hearing

• 18. Tom Woodward

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
17
Open Public Hearing

• 19. Sheila McDonald
• The Child Adolescent Bipolar Foundation

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
18
Open Public Hearing

• 20. John Walkup

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
19
Open Public Hearing

• 21. Mark Taylor
• Donna Taylor

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
20
Open Public Hearing

• 22. Kim Witczak

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
21
Open Public Hearing

• 23. Karen Barth Menzies

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
22
Open Public Hearing

• 24. Lawrence Greenhill
• American Academy of Child Adolescent Psychiatry

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
23
Open Public Hearing

• 26. Lawrence Diller

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
24
Open Public Hearing

• 27. Reese Butler
• Kristin Brooks Hope Center

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
25
Open Public Hearing

• 28. Suzanne Vogel-Scibilia

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
26
Open Public Hearing

• 29. Mary Ellen Winter

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
27
Open Public Hearing

• 30. Beverly Hatcher

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
28
Open Public Hearing

• 31. David Shaffer

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
29
Open Public Hearing

• 32. Mark Miller
• International Coalition
• for Drug Awareness

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
30
Open Public Hearing

• 33. Donald Farber

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
31
Open Public Hearing

• 34. Allan Routhier

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
32
Open Public Hearing

• 35. Sharon McBride

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
33
Open Public Hearing

• 36. Peter Breggin

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
34
Open Public Hearing

• 37. Bruce Orr

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
35
Open Public Hearing

• 38. Jerry Reed
• Suicide Prevention Action Network, USA

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
36
Open Public Hearing

• 39. Chris Coffin

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
37
Open Public Hearing

• 40. Alice Erber

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
38
Open Public Hearing

• 41. Leigh Webb

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
39
Open Public Hearing

• 42. Chester Witzcak

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
40
Open Public Hearing

• 44. Nancy Parker

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
41
Open Public Hearing

• 45. Richard Schneeberg

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
42
Open Public Hearing

• 46. David Risinger

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
43
Open Public Hearing

• 47. David Healy

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
44
Open Public Hearing

• 49. Cynthia Wainscott
• National Mental Health Association

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
45
Open Public Hearing

• 51. Deborah Gruder

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
46
Open Public Hearing

• 52. Mary Guardino
• Freedom from Fear

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
47
Open Public Hearing

• 53. Terri Williams

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
48
Open Public Hearing

• 55. Laurie Yorke

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
49
Open Public Hearing

• 56. Robert Fritz

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
50
Open Public Hearing

• 57. Stuart Varon

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
51
Open Public Hearing

• 58. Julie Zito

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
52
Open Public Hearing

• 60. Adelaide Robb

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
53
Open Public Hearing

• 61. Steve Rebarber

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
54
Open Public Hearing

• 62. Christopher Kratochvil

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
55
Open Public Hearing

• 64. Eric Swan

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
56
Open Public Hearing

• 65. Patty Weathers
• Ablechild

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
57
Open Public Hearing

• 66. Celeste Steubing

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
58
Open Public Hearing

• 68. Robert Mann
• American Foundation for Suicide Prevention

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
59
Open Public Hearing

• 69. Lawrence Brain

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
60
Open Public Hearing

• 70. Mark Shapiro

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
61
Open Public Hearing

• 71. Mathy Milling Downing

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
62
Open Public Hearing

• 72. Peter Kahn

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004
63
Open Public Hearing

• 73. Eileen McGinn

Psychopharmacologic Drugs Advisory Committee
Pediatric Advisory Committee September 13-14,
2004